Related Experiment Video
Updated: Nov 29, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Bleeding events during anticoagulation in patients with hereditary hemorrhagic telangiectasia
Nicolas Tentoni1, Martin I Lapidus2, Veronica A Peuchot3
1Internal Medicine Department, Hospital Italiano de Buenos Aires, City of Buenos Aires 1199, Argentina; Laboratory of Applied Statistics in Health Sciences, Pharmacology Department, School of Medicine, University of Buenos Aires, City of Buenos Aires 1121, Argentina; A.R.G (Argentine Rendu Study Group), Hospital Italiano de Buenos Aires, City of Buenos Aires 1199, Argentina.
No abstract available in PubMed .
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

